Suppr超能文献

两例 HHV-8 无关的 HIV 阴性原发性渗出性淋巴瘤样淋巴瘤患者单纯通过引流排除恶性细胞。

Disappearance of malignant cells by effusion drainage alone in two patients with HHV-8-unrelated HIV-negative primary effusion lymphoma-like lymphoma.

机构信息

Division of Internal Medicine, Toyama City Hospital, 2-1, Hokubu-machi, Imaizumi, Toyama, 939-8511, Japan.

Division of Internal Medicine, Toyama Prefectural Central Hospital, Toyama, Japan.

出版信息

Int J Hematol. 2011 Sep;94(3):279-284. doi: 10.1007/s12185-011-0906-8. Epub 2011 Aug 20.

Abstract

Primary effusion lymphoma (PEL) is a rare type of non-Hodgkin lymphoma usually confined to the body cavities of predominantly immunosuppressed patients infected with human herpes virus-8 (HHV-8). In PEL, malignant cells are usually negative for B-cell markers, such as CD19, CD20, and CD79a, but are positive for activation and plasma cell-related markers, such as CD30, CD38, and CD138. It has been reported that HHV-8-unrelated PEL shows high expression of B-cell markers, which is referred to as PEL-like lymphoma. Here, we report two cases of HHV-8-unrelated HIV-negative PEL-like lymphoma in which malignant cells regressed spontaneously after effusion drainage alone. These cells expressed B-cell markers, such as CD20. No chemotherapy was given to either patient, as they were of an advanced age, and both achieved a complete response by effusion drainage alone. One showed a complete response for 16 months after effusion drainage, and the other has survived for 11 months with a complete response. This suggests that sufficient drainage of serous effusion may induce and maintain a complete response in some patients with HHV-8-unrelated HIV-negative PEL-like lymphoma, which represents an excellent treatment option for elderly patients with this disease.

摘要

原发性渗出性淋巴瘤 (PEL) 是一种罕见的非霍奇金淋巴瘤,通常局限于主要免疫抑制的人类疱疹病毒 8 型(HHV-8)感染患者的体腔中。在 PEL 中,恶性细胞通常对 B 细胞标志物如 CD19、CD20 和 CD79a 呈阴性,但对激活和浆细胞相关标志物如 CD30、CD38 和 CD138 呈阳性。据报道,与 HHV-8 无关的 PEL 表现出高表达 B 细胞标志物,被称为 PEL 样淋巴瘤。在这里,我们报告了两例 HHV-8 无关的 HIV 阴性 PEL 样淋巴瘤,这些恶性细胞在单纯引流积液后自发消退。这些细胞表达 B 细胞标志物,如 CD20。由于患者年龄较大,均未给予化疗,仅通过引流积液就使患者达到完全缓解。其中一例在引流积液后 16 个月完全缓解,另一例完全缓解 11 个月后仍存活。这表明,在某些 HHV-8 无关的 HIV 阴性 PEL 样淋巴瘤患者中,充分引流浆膜积液可能会诱导并维持完全缓解,这是一种针对该疾病老年患者的极佳治疗选择。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验